Recently, there have been several consolidations in the economy, the biotech industry being one.
With the creation of fewer \"Biotech giants worldwide\", will this lead to stronger monopoly
power, thus potentially contributing to rising healthcare costs (prescription drugs), or is it a
necessity of the industry to optimize R&D resources to more rapidly bring new, critical
medicines to market?
**PLEASE NOTE THE ANSWER CURRENTLY POSTED ON CHEGG IS
INCORRRECT*** IT BEGINS WITH \"Biotechnology mergers and acquisitions can help the
industrys fully integrated players to increase in size and market value, boost the emerging
companies efforts to reach full integration or allow the start-ups to survive cyclical financial
crises. M&A in the biotechnology sector (including inter-sector deals between the
pharmaceutical and biotechnology companies or intra-sector deals within the biotechnology
sectors) serves three main purposes, where one company acquires another in order to increase
pipeline productivity and innovation or aid the transition to become full integrated
biopharmaceutical company (FIBCO) or a company merges equally with another to support
product development, market expansion or sustainable profitability.\"\"\" THIS ANSWER IS
INCORRECT. IF YOU WANT FULL POINTS PLEASE ANSWER THE QUESTION
CORRECTLY! THANKS!
Solution
As it is always necessary for any industry to bring newer products into the market as per the
needs of the consumer.
Though this company has a monopoly over the market, it needs to have a research departmrment
to know the current market requirements for grabbing the opeertunities as soon as possible.
And as its a biotech company it must have R & D deparment to handle any critical situation
because they have constant watch on market..
Introduction to ArtificiaI Intelligence in Higher Education
Recite the factors that influence price elasticitySolutionTher.pdf
1. Recite the factors that influence price elasticity
Solution
There are 9 Factors which Affects the Elasticity of Price. They are as follows.
Share in Total Expenditure:
Habits:
Number of Uses:
Income Level:
Nature of commodity:
Availability of substitutes:
Level of price:
Postponement of Consumption:
Time Period:
